CLINICAL_TRIALS
trial_result
· 2025-08-01
Clinical Trial Update: A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) [Phase 1]
Summary
The ASPEN-01 Phase 1 trial of Evorpacept (ALX148) in patients with advanced solid tumors and Non-Hodgkin lymphoma has completed its Phase 1 portion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ALX Oncology Inc. | Conditions: Metastatic Cancer, Solid Tumor | Phase 1 | Status: COMPLETED